Akebia Therapeutics, Inc. AKBA
0.39 USD -0.04 (-8.71%)
Regular-session close
0.40 +0.01 +3.50%
After hours · Nov 20, 7:50 PM ET
0.3849 Day range 0.4331
0.361 52-week range 1.73
- YTD
- -76.06%
- 1 year
- -74.97%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 236.20M | 160.18M | 194.62M | 292.48M | 211.65M | |
| 196.73M | 97.00M | 120.47M | 206.92M | 60.98M | |
| 26.89M | -47.25M | -43.02M | -77.60M | -264.50M | |
| -5.34M | -69.41M | -51.92M | -94.23M | -282.02M | |
| -0.02 | -0.33 | -0.28 | -0.52 | -1.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 184.84M | 51.87M | 42.92M | 90.47M | 149.80M | |
| 376.56M | 220.67M | 241.70M | 356.05M | 529.35M | |
| 343.95M | 269.86M | 272.29M | 350.82M | 455.34M | |
| 48.25M | 42.24M | 43.63M | 152.52M | 131.25M | |
| 32.61M | -49.19M | -30.58M | 5.23M | 74.01M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 67.99M | -40.66M | -23.38M | -73.15M | -252.97M | |
| -7.93M | -33.00K | 0 | -114.00K | 39.94M | |
| 72.93M | 49.66M | -25.21M | 14.60M | 133.73M | |
| 132.99M | 8.97M | -48.59M | -58.67M | -79.29M |
